Godavari Drugs Limited (BOM:530317)
88.70
-0.98 (-1.09%)
At close: Feb 12, 2026
Godavari Drugs Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 22.93 | 23.73 | 26.23 | 30.85 | 22.76 | 16.38 |
Cash & Short-Term Investments | 22.93 | 23.73 | 26.23 | 30.85 | 22.76 | 16.38 |
Cash Growth | -23.01% | -9.52% | -14.97% | 35.50% | 38.95% | 14.84% |
Accounts Receivable | 417.88 | 423.24 | 594.23 | 579.35 | 555.79 | 451.21 |
Other Receivables | - | 8.52 | 11.73 | 11.12 | 14.14 | 9.06 |
Receivables | 427.21 | 441.98 | 614.91 | 599.35 | 576.02 | 465.94 |
Inventory | 362.43 | 279.41 | 206.51 | 198.56 | 100.34 | 146.5 |
Other Current Assets | 71.4 | 42.5 | 37.16 | 41.31 | 44.23 | 47.31 |
Total Current Assets | 883.97 | 787.63 | 884.81 | 870.06 | 743.34 | 676.13 |
Property, Plant & Equipment | 722.96 | 625.55 | 450.05 | 339.85 | 267.41 | 231.92 |
Long-Term Investments | 0 | 1.13 | 1.13 | 1.02 | 1.02 | 0 |
Other Long-Term Assets | 17.7 | 16.46 | 11.55 | 3.4 | 2.34 | 3.34 |
Total Assets | 1,625 | 1,431 | 1,348 | 1,214 | 1,014 | 911.4 |
Accounts Payable | 308.53 | 287.06 | 316.27 | 246.73 | 433.17 | 295.05 |
Accrued Expenses | - | 4.07 | 8.58 | 5.87 | 3.7 | 16.83 |
Short-Term Debt | 440.67 | 377.33 | 444.58 | 430.25 | 85.61 | 135.89 |
Current Portion of Long-Term Debt | - | 27.18 | 21.45 | 23.5 | 27.29 | 23.8 |
Current Income Taxes Payable | 16.05 | 11.9 | 11.55 | 10.17 | 12.27 | 11.88 |
Other Current Liabilities | 78.91 | 23.37 | 17.57 | 20.57 | 15.57 | 21.68 |
Total Current Liabilities | 844.15 | 730.9 | 820 | 737.08 | 577.61 | 505.12 |
Long-Term Debt | 298.62 | 238.95 | 111.67 | 119.48 | 117.82 | 144.9 |
Pension & Post-Retirement Benefits | 9.14 | 8.26 | 7.56 | 7.14 | 7.23 | 7.87 |
Long-Term Deferred Tax Liabilities | 18.86 | 19.18 | 18.63 | 16.46 | 15.14 | 9.65 |
Other Long-Term Liabilities | - | - | - | 0 | 0 | - |
Total Liabilities | 1,171 | 997.3 | 957.86 | 880.16 | 717.8 | 667.54 |
Common Stock | 75.31 | 75.31 | 75.31 | 75.31 | 75.31 | 75.31 |
Additional Paid-In Capital | - | 106.32 | 106.32 | 106.32 | 106.32 | 106.32 |
Retained Earnings | - | 246.34 | 202.54 | 147.05 | 109.19 | 56.74 |
Comprehensive Income & Other | 378.57 | 5.5 | 5.5 | 5.5 | 5.5 | 5.5 |
Shareholders' Equity | 453.87 | 433.46 | 389.66 | 334.17 | 296.31 | 243.86 |
Total Liabilities & Equity | 1,625 | 1,431 | 1,348 | 1,214 | 1,014 | 911.4 |
Total Debt | 739.28 | 643.46 | 577.7 | 573.22 | 230.73 | 304.58 |
Net Cash (Debt) | -716.35 | -619.73 | -551.47 | -542.38 | -207.96 | -288.2 |
Net Cash Per Share | -95.19 | -82.35 | -73.25 | -72.06 | -27.63 | -38.26 |
Filing Date Shares Outstanding | 7.52 | 7.53 | 7.53 | 7.53 | 7.53 | 7.53 |
Total Common Shares Outstanding | 7.52 | 7.53 | 7.53 | 7.53 | 7.53 | 7.53 |
Working Capital | 39.82 | 56.73 | 64.81 | 132.98 | 165.73 | 171.02 |
Book Value Per Share | 60.32 | 57.56 | 51.74 | 44.38 | 39.35 | 32.38 |
Tangible Book Value | 453.87 | 433.46 | 389.66 | 334.17 | 296.31 | 243.86 |
Tangible Book Value Per Share | 60.32 | 57.56 | 51.74 | 44.38 | 39.35 | 32.38 |
Land | - | 22.67 | 0.33 | 0.33 | 0.33 | 0.33 |
Buildings | - | 56.5 | 56.5 | 44.59 | 44.59 | 44.03 |
Machinery | - | 415.1 | 411.92 | 417.9 | 450.75 | 396.18 |
Construction In Progress | - | 299.46 | 183.21 | 90.75 | 4.9 | 7.58 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.